Magnesium Malate vs Glycinate — the energy form and the sleep form
Both magnesium malate and magnesium glycinate are well-absorbed organic forms with mild GI footprints, far above magnesium oxide on bioavailability and far below it on laxative effect. They differ in the chelator: malate (malic acid, a Krebs cycle intermediate) leans toward daytime energy and muscle pain endpoints; glycinate (with glycine, an inhibitory neurotransmitter) leans toward evening sleep and anxiety endpoints. The good news for most users is that these aren't really competitors — the cleanest stack is malate in the morning and glycinate at night.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Fibromyalgia / muscle pain / chronic fatigue | Malate | Small open-label and crossover trials of magnesium + malic acid suggest tender-point and pain reductions; malate may support muscular ATP production. |
| Sleep onset and maintenance | Glycinate | Glycine itself has independent sleep-quality data; the chelator contributes a mild calming profile beyond the magnesium. |
| Anxiety and stress reactivity | Glycinate | The combined magnesium + glycine effect aligns with the GABA-A modulation pathway. |
| Morning grogginess after high-dose magnesium | Malate | Malate's slight energising profile is less likely to add to sleep inertia if taken in the morning. |
| Migraine prevention (AAN Grade B) | Either (dose is what matters) | The 400–600 mg elemental dose is what's evidenced — form preference is secondary to dose. |
| Constipation | Neither (use citrate or oxide) | Both malate and glycinate are gentler — wrong tool for laxative effect. |
How they compare on biology
What the chelator does
Magnesium glycinate (technically magnesium bisglycinate) pairs each magnesium ion with two glycine molecules. Glycine itself is an inhibitory neurotransmitter at the brainstem and spinal cord and has independent evidence for improving subjective sleep quality at 3 g doses. The combined supplement therefore brings two complementary mechanisms to evening dosing. Magnesium malate uses malic acid — a Krebs (citric acid) cycle intermediate. Malic acid is involved in cellular ATP production, and proponents argue this matters for fibromyalgia and chronic fatigue where mitochondrial ATP turnover is implicated. The clinical evidence for "energising" malate is weaker than the sleep evidence for glycinate, but the directional finding is consistent across small trials.
Bioavailability
Both forms have meaningfully higher serum elevation than magnesium oxide (which is ~4% absorbed) and are similar to magnesium citrate on absorption metrics. Pharmacokinetic head-to-heads between malate and glycinate are limited but show comparable systemic exposure at equivalent elemental magnesium doses. Practically, both achieve the systemic magnesium repletion any general-purpose user wants without the GI cost.
Elemental magnesium per dose
Magnesium glycinate is approximately 14% elemental magnesium by weight; magnesium malate is approximately 6.5% elemental. This means achieving an evening dose of 300 mg elemental magnesium requires roughly 2.1 g of glycinate vs 4.6 g of malate — many users find they need more pills with malate. Read the label for elemental content (the headline mg is sometimes total compound, not elemental).
GI tolerance
Both forms are gentler on GI than citrate or oxide. Glycinate may have a slight edge for users with reflux or IBS. Doses above 400 mg elemental in either form will loosen stools in most users; this is dose-dependent, not form-dependent.
Who should consider supplementing at all
Adults with low dietary magnesium intake (typical Western diet runs below the 320 mg/d RDA for women and 420 mg/d for men), users with diabetes or insulin resistance (both deplete magnesium), users on PPIs or loop diuretics (both lower magnesium), users with documented hypomagnesemia, and users targeting specific magnesium-evidenced endpoints (migraine prevention, sleep, RLS, leg cramps).
Who should skip
Users on dialysis or with eGFR <30 mL/min — magnesium excretion is impaired and clinically significant hypermagnesemia is a real risk. Discuss with prescriber. Users already getting >300 mg/d magnesium from diet (leafy greens, legumes, seeds, dark chocolate) without symptoms — the marginal benefit is small.
Drug interactions
Space magnesium at least 2 hours from oral antibiotics (tetracyclines, fluoroquinolones), bisphosphonates, and levothyroxine — magnesium chelates these and reduces their absorption. Coordinate with prescriber if on lithium or potassium-sparing diuretics.
What the price difference buys you
Glycinate runs $0.20–0.40/day at 300 mg elemental; malate runs $0.15–0.30/day at 300 mg elemental. Reputable brands (Doctor's Best, NOW, Pure Encapsulations, Thorne) charge a small premium for verified low-oxide formulation — many cheap "magnesium glycinate" products are actually magnesium oxide/glycinate buffered blends with the glycinate as a minority.
What we'd actually buy
For an evening-only single product: a verified magnesium bisglycinate (not buffered with oxide), 200–400 mg elemental, 60–90 minutes before bed.
For a two-form stack in fibromyalgia or chronic fatigue: magnesium malate 300 mg elemental with breakfast + magnesium bisglycinate 200 mg elemental at bedtime.
For migraine prevention: prioritise hitting 400–600 mg elemental daily; form is secondary. Glycinate splits AM/PM well at this dose; malate splits AM/lunch.
Sources
- Russell IJ, et al. Treatment of fibromyalgia syndrome with super malic: a randomized, double blind, placebo controlled, crossover pilot study. J Rheumatol. 1995;22(5):953–958. PMID: 8587088
- Bannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J Pharmacol Sci. 2012;118(2):145–148. PMID: 22293292
- Schuette SA, et al. Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection. JPEN J Parenter Enteral Nutr. 1994;18(5):430–435. PMID: 7815675
- Walker AF, et al. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003;16(3):183–191. PMID: 14596323
- Peikert A, et al. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257–263. PMID: 8792038
- Boyle NB, et al. The effects of magnesium supplementation on subjective anxiety and stress — a systematic review. Nutrients. 2017;9(5):429. PMID: 28445426